<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2869
  </number>
  <updateDate>
   2023-01-11T13:48:33Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:33Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-28
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 73 (Wednesday, April 28, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. CARDENAS:H.R. 2869.Congress has the power to enact this legislation pursuantto the following:Article 1 Section 8 of the U.S. Constitution[Page H2127]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-29T17:51:00Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-28T22:04:10Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hswm02
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-28T18:11:35Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-28T22:04:15Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Increasing Access to Biosimilars Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     1427
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-04-28
     </actionDate>
     <text>
      Read twice and referred to the Committee on Finance.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-04-29
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hswm02
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     C001097
    </bioguideId>
    <fullName>
     Rep. Cárdenas, Tony [D-CA-29]
    </fullName>
    <firstName>
     Tony
    </firstName>
    <lastName>
     Cárdenas
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     29
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     C001119
    </bioguideId>
    <fullName>
     Rep. Craig, Angie [D-MN-2]
    </fullName>
    <firstName>
     Angie
    </firstName>
    <lastName>
     Craig
    </lastName>
    <party>
     D
    </party>
    <state>
     MN
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-04-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001303
    </bioguideId>
    <fullName>
     Rep. Blunt Rochester, Lisa [D-DE-At Large]
    </fullName>
    <firstName>
     Lisa
    </firstName>
    <lastName>
     Blunt Rochester
    </lastName>
    <party>
     D
    </party>
    <state>
     DE
    </state>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-05-11
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Medicare
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-28
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-06-25T21:00:05Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Increasing Access to Biosimilars Act of &lt;/b&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill requires the Centers for Medicare &amp;amp; Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead. &lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Increasing Access to Biosimilars Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Increasing Access to Biosimilars Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Increasing Access to Biosimilars Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-28T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2869ih/xml/BILLS-117hr2869ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-29
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-29
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-28
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-28
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
2021-04-28
Health Subcommittee
hswm02
1
House committee actions
Referred to the Subcommittee on Health.
Committee
Intro-H
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
2021-04-28T22:04:10Z
Referred to
House
Energy and Commerce Committee
2021-04-29T17:51:00Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-04-28T22:04:15Z
Referred to
House
Ways and Means Committee
2021-04-28T18:11:35Z
Referred to
Health Subcommittee
hswm02
hswm00
Standing
C001119
2
Angie
Rep. Craig, Angie [D-MN-2]
Craig
D
2021-04-28
MN
B001303
0
Lisa
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Blunt Rochester
D
2021-05-11
DE
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-28
2021-04-29
Referred to the Subcommittee on Health.
House
Health
2021-04-28
Read twice and referred to the Committee on Finance.
CRS
Related bill
Increasing Access to Biosimilars Act of 2021
S
C001097
29
Tony
Rep. Cárdenas, Tony [D-CA-29]
N
Cárdenas
D
CA
Congressional oversight Government studies and investigations Health care costs and insurance Medicare Prescription drugs
2021-04-28
Introduced in House
 <p><b>Increasing Access to Biosimilars Act of </b><b>2021</b></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead. </p>
2021-06-25T21:00:05Z
00
2021-04-28T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2869ih/xml/BILLS-117hr2869ih.xml
Increasing Access to Biosimilars Act of 2021
Increasing Access to Biosimilars Act of 2021
Display Title
IH
Introduced in House
To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Official Title as Introduced
IH
Introduced in House
Increasing Access to Biosimilars Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:48:33Z
2023-01-11T13:48:33Z
3.0.0
2021-04-28
Read twice and referred to the Committee on Finance.
CRS
Related bill
Increasing Access to Biosimilars Act of 2021
S
2021-04-29
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-28
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-28
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
2021-04-28
Health Subcommittee
hswm02
1
House committee actions
Referred to the Subcommittee on Health.
Committee
Intro-H
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
C001097
29
Tony
Rep. Cárdenas, Tony [D-CA-29]
N
Cárdenas
D
CA
C001119
2
Angie
Rep. Craig, Angie [D-MN-2]
Craig
D
2021-04-28
MN
B001303
0
Lisa
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Blunt Rochester
D
2021-05-11
DE
Congressional oversight Government studies and investigations Health care costs and insurance Medicare Prescription drugs
2021-04-28
Introduced in House
 <p><b>Increasing Access to Biosimilars Act of </b><b>2021</b></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead. </p>
2021-06-25T21:00:05Z
00
Increasing Access to Biosimilars Act of 2021
Increasing Access to Biosimilars Act of 2021
Display Title
IH
Introduced in House
To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Official Title as Introduced
IH
Introduced in House
Increasing Access to Biosimilars Act of 2021
Short Title(s) as Introduced
2021-04-29
Referred to the Subcommittee on Health.